BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 17885582)

  • 21. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
    Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
    Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NEMO-binding domain peptide inhibits proliferation of human melanoma cells.
    Ianaro A; Tersigni M; Belardo G; Di Martino S; Napolitano M; Palmieri G; Sini M; De Maio A; Ombra M; Gentilcore G; Capone M; Ascierto M; Satriano RA; Farina B; Faraone-Mennella M; Ascierto PA; Ialenti A
    Cancer Lett; 2009 Feb; 274(2):331-6. PubMed ID: 19004544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
    Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
    Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
    Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
    Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
    Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
    Kishida Y; Yoshikawa H; Myoui A
    Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.
    Kuo PL; Hsu YL; Lin TC; Tzeng WS; Chen YY; Lin CC
    Cancer Lett; 2007 Apr; 248(2):280-91. PubMed ID: 16963181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis.
    Kim MO; Moon DO; Heo MS; Lee JD; Jung JH; Kim SK; Choi YH; Kim GY
    Cancer Lett; 2008 Nov; 271(1):25-33. PubMed ID: 18602210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways.
    Liao S; Xia J; Chen Z; Zhang S; Ahmad A; Miele L; Sarkar FH; Wang Z
    J Cell Biochem; 2011 Apr; 112(4):1055-65. PubMed ID: 21308734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
    Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L
    Clin Cancer Res; 2007 Oct; 13(19):5942-51. PubMed ID: 17908991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.
    Yemelyanov A; Gasparian A; Lindholm P; Dang L; Pierce JW; Kisseljov F; Karseladze A; Budunova I
    Oncogene; 2006 Jan; 25(3):387-98. PubMed ID: 16170348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
    Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
    Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity.
    Liang MC; Bardhan S; Pace EA; Rosman D; Beutler JA; Porco JA; Gilmore TD
    Biochem Pharmacol; 2006 Feb; 71(5):634-45. PubMed ID: 16360644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis by melampolides and repandolides.
    Ma G; Khan SI; Benavides G; Schühly W; Fischer NH; Khan IA; Pasco DS
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):35-43. PubMed ID: 17149609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
    Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
    J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
    Shishodia S; Amin HM; Lai R; Aggarwal BB
    Biochem Pharmacol; 2005 Sep; 70(5):700-13. PubMed ID: 16023083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.